Sudarshan Pharma Industries Ltd — Updates, 19-06-2025: Company Update

Sudarshan Pharma has announced a board meeting to approve the incorporation of a wholly-owned subsidiary in Canada focused on manufacturing chemical pharmaceutical products and trading in FMCG. This move marks Sudarshan’s entry into the Canadian market through a new limited liability company. The incorporation process is expected to complete within six months. This international expansion aligns with Sudarshan Pharma’s growth ambitions and could enhance its global footprint, offering potential new revenue streams for shareholders.